Figure 4.
Distribution of mutations in AML-TP53 and AML-MR. Mutations and cytogenetic abnormalities are shown for patients with AML-TP53 and AML-MR with wild-type TP53, with each row representing a gene and each column representing a patient. The number (percent) of patients in each group harboring different types of mutations is shown at the right. chrom, chromatin modifier; mut, mutation; TF, transcription factor; TK, tyrosine kinase. Figure generated using cBioPortal, as previously described.29,30

Distribution of mutations in AML-TP53 and AML-MR. Mutations and cytogenetic abnormalities are shown for patients with AML-TP53 and AML-MR with wild-type TP53, with each row representing a gene and each column representing a patient. The number (percent) of patients in each group harboring different types of mutations is shown at the right. chrom, chromatin modifier; mut, mutation; TF, transcription factor; TK, tyrosine kinase. Figure generated using cBioPortal, as previously described.29,30 

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal